Regulus Therapeutics
RGLS
#9072
Rank
A$0.15 B
Marketcap
$2.34
Share price
7.25%
Change (1 day)
-36.45%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$10.99 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are A$10.99 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$14.03 M-28.85%
2022-12-31A$19.72 M5.98%
2021-12-31A$18.61 M23.63%
2020-12-31A$15.05 M-52.22%
2019-12-31A$31.51 M-34.27%
2018-12-31A$47.95 M-12.11%
2017-12-31A$54.55 M-11.8%
2016-12-31A$61.85 M164.98%
2015-12-31A$23.34 M-51.59%
2014-12-31A$48.22 M45.28%
2013-12-31A$33.19 M-16.73%
2012-12-31A$39.86 M-51.56%
2011-12-31A$82.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$92.00 B 836,332.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$90.38 B 821,578.64%๐Ÿ‡ซ๐Ÿ‡ท France
A$17.91 B 162,781.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$99.85 B 907,689.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$6.59 B 59,872.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.11 B 936.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$120.48 B 1,095,257.86%๐Ÿ‡บ๐Ÿ‡ธ USA